The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer.

NPJ Breast Cancer · 2022 · PMC9352750 · PMID 35927391

Europe PMC DOI

hedged sentence

0.1480

closest p · 3.0× alpha

0.1480

boldest claim

The sentences

did not reach statistical significancep = 0.148not close (p > 0.1)

Considering residual Ki67, the direction of association terms were conserved but did not reach statistical significance (OR: 1.52, 95%CI: 0.87–3.19, p = 0.148, OR: 1.08, 95%CI: 0.98–1.23, p = 0.124, distant adipocyte diameter and area, respectively and OR: 1.35, 95%CI: 0.65–3.77, p = 0.458, OR: 1.06, 95%CI: 0.90–1.36, p = 0.514 CAAs diameter and area, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.